...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Drug safety issues of nimesulide in China--nimesulide-induced liver injury.
【24h】

Drug safety issues of nimesulide in China--nimesulide-induced liver injury.

机译:中国尼美舒利的药物安全性问题-尼美舒利引起的肝损伤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nimesulide is a non-steroidal anti-inflammatory drug. It is considered to be well-tolerated and has a relatively low occurrence of adverse drug reactions (ADRs) especially in the gastrointestinal tracts. Because its antipyretic effect is quick, nimesulide has become the saleable first-line medicine for fever in children, particularly in poor and backward areas, in China since 2002. Shelves are filled with various brands of pharmaceutical formulations of nimesulide in pharmacy throughout the country. Because drug supervision and management is lax in China, an anxious parent can purchase nimesulide easily for his or her child in fever in most urban and rural pharmacies, even though he or she has not obtained regular prescription from pediatrician.
机译:尼美舒利是一种非甾体类抗炎药。人们认为它具有良好的耐受性,尤其是在胃肠道中,药物不良反应(ADR)的发生率相对较低。由于尼美舒利具有快速的解热作用,自2002年以来,它已成为中国儿童,特别是在贫困和落后地区的发烧的首选一线药物。在全国各地的药房中,货架上摆满了各种品牌的尼美舒利药物制剂。由于中国的药品监督管理不严,即使在父母没有从儿科医生那里获得常规处方的情况下,焦虑的父母也可以在大多数城市和乡村药房为他或她的孩子容易地购买尼美舒利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号